Mailing Colorectal Cancer Screening Kits Found Effective, Regardless of...
When patients do not keep up with screening, the risk of death is substantially higher, so Penn Medicine researchers, investigating a new way to boost screening among those who were overdue, found a...
View ArticlePenn’s IMPaCT Community Health Worker Program Receives Federal Award to...
Penn Medicine’s IMPaCT (Individualized Management for Patient-Centered Targets) program has received a 3-year, $1.4 million award from the Patient-Centered Outcomes Research Institute (PCORI) to help...
View ArticlePenn Medicine at the 2019 American Association for Cancer Research Annual...
Experts from the Perelman School of Medicine at the University of Pennsylvania will be presenting data on the latest advances in cancer research and treatment at AACR's Annual Meeting in Atlanta from...
View ArticlePenn Researchers Discover the Source of New Neurons in Brain Hippocampus
Researchers from the Perelman School of Medicine at the University of Pennsylvania have shown, in mice, that one type of stem cell that makes adult neurons is the source of this lifetime stock of new...
View ArticleDoctors More Likely to Prescribe Preventive Therapy When Prompted by EMR...
Purely educating doctors about the importance of prescribing certain therapies may not be enough to make a meaningful impact, according to a new Penn Medicine study.
View ArticleCD40 Combination Therapy Can Shrink Pancreatic Tumors
A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumors to shrink in the majority of evaluable patients – 20 out of 24 as of an interim analysis of the phase 1b trial data.
View ArticleTargeted Drug for Leukemia Tested at Penn Medicine Helps Patients Live Longer
An inhibitor drug that targets a specific mutation in relapsed or refractory acute myeloid leukemia (AML) helps patients live almost twice as long as those who receive chemotherapy.
View ArticlePARP Inhibitors Can Shrink Tumors in Pancreatic Cancer Patients with Specific...
Switching pancreatic cancer patients to the PARP inhibitor rucaparib as maintenance therapy instead of continuing intensive chemotherapy either shrunk tumors or stopped them from growing in 17 of 19...
View ArticleStudy Reveals Both Overlapping and Distinct Genes Associated with Heavy...
A large genomic study of nearly 275,000 people led by Penn Medicine researchers revealed new insights into genetic drivers of heavy drinking and alcohol use disorder (AUD), the uncontrollable pattern...
View ArticleTopical Targeted Therapies Show Promise in Treatment of Skin Cancer
Treating precancerous skin lesions with topical targeted therapies may significantly reduce their size and inhibit the growth of cutaneous squamous cell carcinoma, the second most common form of...
View ArticleAwards & Accolades: March 2019
Learn how Penn clinicians and researchers are being honored by their peers.
View ArticleSix Penn Medicine Physician-Scientists Elected to the Association of American...
Six physician-scientists from the Perelman School of Medicine at the University of Pennsylvania have been elected to the Association of American Physicians, one of the nation’s most prestigious medical...
View ArticlePenn-Led Study Finds Childhood Trauma Has Lasting Effect on Brain...
PHILADELPHIA – A study lead by Penn Medicine researchers found that childhood trauma is linked to abnormal connectivity in the brain in adults with major depressive disorder (MDD).
View ArticleKatherine L. Nathanson, MD, Named Inaugural Pearl Basser Professor for...
A new gift to support the Basser Center for BRCA at the University of Pennsylvania’s Abramson Cancer Center (ACC) established and endowed the Pearl Basser Professorship for BRCA-Related Research....
View ArticleApp Predicts Risk of Developing Hernia Following Abdominal Surgery
A new app can predict the likelihood that a patient will develop an incisional hernia following abdominal surgery, using big data to potentially help address a problem effects one out of every eight of...
View ArticleFirst-Year Doctors Spend Almost 90 Percent of Their Time Away from Patients
First-year doctors, or interns, spend 87 percent of their work time away from patients, half of which is spent interacting with electronic health records, according to a new study from researchers at...
View ArticleResearchers Use Gene Editing with CRISPR to Treat Lethal Lung Diseases Before...
Using CRISPR gene editing, a team from Penn Medicine and Children’s Hospital of Philadelphia (CHOP) have thwarted a lethal lung disease, in an animal model, in which a harmful mutation causes death...
View ArticleCertain Strains of Bacteria Associated with Diabetic Wounds That Do Not Heal
A new study from the Perelman School of Medicine at the University of Pennsylvania found specific strains of the common pathogen Staphylococcus aureus (S. aureus) are associated with wounds that do not...
View ArticlePenn Immunologist and Collaborators Receive $10 Million NIH Renewal to Study...
E. John Wherry, PhD, the chair of Pharmacology at the Perelman School of Medicine of the University of Pennsylvania, will lead the Penn team in the collaboration to study the impact of an immunotherapy...
View ArticlePenn Medicine Announces Tara Miller Melanoma Center
The Abramson Cancer Center at the University of Pennsylvania is establishing the Tara Miller Melanoma Center, which will focus on the accelerated development of novel therapies and improved clinical...
View Article